Colette Smit

3.0k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Colette Smit is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Colette Smit has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 27 papers in Epidemiology and 22 papers in Hepatology. Recurrent topics in Colette Smit's work include Hepatitis C virus research (21 papers), HIV/AIDS Research and Interventions (19 papers) and HIV/AIDS drug development and treatment (16 papers). Colette Smit is often cited by papers focused on Hepatitis C virus research (21 papers), HIV/AIDS Research and Interventions (19 papers) and HIV/AIDS drug development and treatment (16 papers). Colette Smit collaborates with scholars based in Netherlands, United Kingdom and United States. Colette Smit's co-authors include Ard van Sighem, Kees Brinkman, Suzanne E. Geerlings, Timothy B. Hallett, Mikaëla Smit, Frank de Wolf, Roel A. Coutinho, Maria Prins, Charlotte van den Berg and Peter Reiss and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Colette Smit

44 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

2015 619 citations Mikaëla Smit, Kees Brinkman et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Colette Smit

Since Specialization

Citations

This map shows the geographic impact of Colette Smit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colette Smit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colette Smit more than expected).

Fields of papers citing papers by Colette Smit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colette Smit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colette Smit. The network helps show where Colette Smit may publish in the future.

Co-authorship network of co-authors of Colette Smit

This figure shows the co-authorship network connecting the top 25 collaborators of Colette Smit. A scholar is included among the top collaborators of Colette Smit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colette Smit. Colette Smit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Prevalence of Posttraumatic Stress Disorder Symptoms Found in Well-Treated People with HIV after the Introduction of Patient-Reported Outcome Measures 2025 ·AIDS and Behavior ·(unknown), Colette Smit, Pythia T. Nieuwkerk, (unknown), (unknown), Jeannine F. Nellen, Kim Sigaloff, Annouschka M. Weijsenfeld, Laura Laan, (unknown), Suzanne E. Geerlings, Marc van der Valk	0
2	Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe 2023 ·Journal of Hepatology ·(unknown), (unknown), Marı́a Buti, Özgür M. Koc, Kosh Agarwal, Robert J. de Knegt, Harry L.A. Janssen, Marc van der Valk, (unknown), Bettina E. Hansen, Matthijs Kramer, Joep de Bruijne, Mark A. A. Claassen, Colette Smit, Rob A. de Man, (unknown), Ivana Carey, Milan J. Sonneveld	8
3	Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study 2023 ·The Lancet Public Health ·(unknown), Anders Boyd, Rachel Sacks‐Davis, Daniela K van Santen, Colette Smit, Marianne Martinello, Mark Stoové, Juan Berenguer, Linda Wittkop, Marina B. Klein, Andri Rauch, Dominique Salmon, Karine Lacombe, (unknown), Janke Schinkel, Joseph Doyle, Margaret Hellard, Marc van der Valk, Gail Matthews	2
4	Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study 2020 ·PLoS Medicine ·Casper Rokx, (unknown), Colette Smit, Ferdinand W.N.M. Wit, (unknown), Peter Reiss, Suzanne C. Cannegieter, Willem M. Lijfering, Karina Meijer, Wouter F.W. Bierman, (unknown), Bart Rijnders, (unknown)	21
5	Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture–recapture analysis for the 2013 to 2016 period 2020 ·Eurosurveillance ·T. Sonia Boender, Eline Op de Coul, Joop E. Arends, Maria Prins, Marc van der Valk, Jan T. M. van der Meer, Birgit van Benthem, Peter Reiss, Colette Smit	2
6	Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM 2019 ·AIDS ·Astrid M. Newsum, Katherine W. Kooij, Anders Boyd, Colette Smit, Ferdinand W.N.M. Wit, Jan T. M. van der Meer, Maria Prins, Peter Reiss, Marc van der Valk	4
7	AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile 2018 ·BMJ Open ·T. Sonia Boender, Colette Smit, Ard van Sighem, Daniela Bezemer, (unknown), S Zaheri, Ferdinand W N M Wit, Peter Reiss	63
8	Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age 2018 ·PLoS ONE ·(unknown), Colette Smit, Mieke H. Godfried, Rachel Bakker, (unknown), Vincent W. V. Jaddoe, Elisabeth van Leeuwen, Peter Reiss, Eric A.P. Steegers, Marc van der Valk	41
9	Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study 2016 ·The Journal of Infectious Diseases ·Lene Ryom, Jens Lundgren, Mike Ross, Ole Kirk, Matthew Law, Philippe Morlat, Éric Fontas, Colette Smit, Christoph A. Fux, Camilla Ingrid Hatleberg, Stéphane De Wit, Caroline Sabin, Amanda Mocroft	39
10	Future challenges for clinical care of an ageing population infected with HIV: a modelling study breakdown → 2015 ·The Lancet Infectious Diseases ·Mikaëla Smit, Kees Brinkman, Suzanne E. Geerlings, Colette Smit, (unknown), Ard van Sighem, Frank de Wolf, Timothy B. Hallett	619
11	Diminished Impact of Ethnicity as a Risk Factor for Chronic Kidney Disease in the Current HIV Treatment Era 2015 ·The Journal of Infectious Diseases ·Annelot F. Schoffelen, Colette Smit, S.F.L. van Lelyveld, Liffert Vogt, (unknown), Peter Reiss, Andy I. M. Hoepelman, Roos E. Barth	6
12	Changes in HIV RNA and CD4 Cell Count After Acute HCV Infection in Chronically HIV-Infected Individuals 2014 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Luuk Gras, Frank de Wolf, Colette Smit, Maria Prins, Jan T. M. van der Meer, Joost W. Vanhommerig, Aeilko H. Zwinderman, Janke Schinkel, Ronald B. Geskus	7
13	Effect of Hepatitis C Treatment on Cd4⁺ T-C El L Counts And The Risk Of Death In HIV–HCV-Coinfected Patients: The Cohere Collaboration 2012 ·Antiviral Therapy ·Colette Smit, Jonathan A C Sterne, Antonella d’Arminio Monforte, (unknown), Frank de Wolf, Lars Peters, Bruno Ledergerber, Stéphane De Wit, (unknown), Andri Rauch, François Dabis	7
14	Could better tolerated HIV drug regimens improve patient outcome? 2012 ·AIDS ·Mikaëla Smit, Colette Smit, Íde Cremin, Geoffrey P. Garnett, Timothy B. Hallett, Frank de Wolf	9
15	Episodes of HIV Viremia and the Risk of Non-AIDS Diseases in Patients on Suppressive Antiretroviral Therapy 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Shuangjie Zhang, Ard van Sighem, Anouk M Kesselring, Luuk Gras, Colette Smit, Jan M. Prins, Robert H. Kauffmann, Clemens Richter, Frank de Wolf, Peter Reiss	28
16	Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy 2011 ·Clinical Infectious Diseases ·A Kesselring, Luuk Gras, Colette Smit, G. van Twillert, Annelies Verbon, Florian Wolf, (unknown), Ferdinand Wit	70
17	Lymphogranuloma Venereum Proctitis in Men Who Have Sex With Men Is Associated With Anal Enema Use and High-Risk Behavior 2008 ·Sexually Transmitted Diseases ·Henry J.C. de Vries, Akke K. van der Bij, Johan S. A. Fennema, Colette Smit, Frank de Wolf, Maria Prins, Roel A. Coutinho, Servaas A. Morré	71
18	Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Colette Smit, Charlotte van den Berg, Ronald B. Geskus, Ben Berkhout, Roel A. Coutinho, Maria Prins	63
19	Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users 2007 ·Addiction ·Charlotte van den Berg, Colette Smit, (unknown), Roel A. Coutinho, Maria Prins	246
20	Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000 2002 ·The Pediatric Infectious Disease Journal ·Susan van den Hof, Colette Smit, Jim van Steenbergen, Hester E. de Melker	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact